Ho-Chang Kuo – Pediatrics – Outstanding Scientist Award
Prof Dr. Ho- Chang Kuo distinguished academic and researcher in the field Pediatrics. He has held various academic appointments throughout his career. In 2004, he started as an Attending Staff member at the Department of Pediatrics specializing in Allergy, Immunology, and Rheumatology at Kaohsiung Chang Gung Memorial Hospital in Taiwan. Over the years, he progressed in his career, becoming a Lectorate attending physician at the same hospital in 2008 and at Chang Gung University in 2009. By 2010, he attained the position of Assistant Professor at Kaohsiung Chang Gung Memorial Hospital, followed by a similar appointment at Chang Gung University in 2011. His dedication and contributions led to his promotion to Associate Professor at Kaohsiung Chang Gung Memorial Hospital in 2013 and at Chang Gung University in 2015. Finally, in 2017, he achieved the esteemed title of Professor at Kaohsiung Chang Gung Memorial Hospital, solidifying his expertise and leadership in his field.
Educations📚📚📚
As the Principal Investigator, he has spearheaded numerous research projects aimed at elucidating various aspects of Kawasaki disease and related immunological phenomena. Among these projects are investigations into the biomarkers and immunopathogenesis of coronary artery lesions in Kawasaki disease, funded by the Cardiac Children’s Foundation Taiwan. He has also delved into topics such as the role of SOCS-1 expression on the TLR4 dependent pathway, DC-SIGN polymorphism, and the impact of IL2RA variants on coronary artery lesions, each supported by grants from entities like Chang Gung Medical Research Program and the National Science Council of Taiwan.
Additionally, he has explored the epigenetic changes and immune responses associated with Kawasaki disease, as well as the effects of prenatal dexamethasone exposure on immune regulation. His research extends beyond Kawasaki disease to investigate broader topics such as the modulation of atopy after probiotic administration, cytokine changes following ECMO setting changes, and neurodevelopment in children post-Kawasaki disease. Furthermore, he has led integrative projects and studies examining T cell receptor involvement in Kawasaki disease, emphasizing his comprehensive approach to understanding immune-related disorders. These endeavors have been supported by various research grants, demonstrating his commitment to advancing medical knowledge and improving patient outcomes.